scholarly article | Q13442814 |
P356 | DOI | 10.1002/GCC.10123 |
P8608 | Fatcat ID | release_fj6bdnczrza6bkza7sapv6vpby |
P698 | PubMed publication ID | 12378530 |
P50 | author | Noboru Nakaigawa | Q87997874 |
P2093 | author name string | Minoru Yoshida | |
Isao Ishikawa | |||
Takeshi Kishida | |||
Masahiro Yao | |||
Yoji Nagashima | |||
Kei-ichi Kondo | |||
Masahiko Hosaka | |||
P2860 | cites work | Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function | Q22009393 |
Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein | Q24599442 | ||
Identification of the von Hippel-Lindau disease tumor suppressor gene | Q29618644 | ||
Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC | Q29937783 | ||
Renal cell carcinomas in patients on long-term hemodialysis | Q33794049 | ||
Chasing the cancer demon | Q34090719 | ||
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype | Q35787720 | ||
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma | Q35807817 | ||
Acquired cystic kidney disease: occurrence, prevalence, and renal cancers | Q38112679 | ||
An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association | Q40914690 | ||
Tumour suppression by the human von Hippel-Lindau gene product | Q41320477 | ||
Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3p. | Q41790952 | ||
Mutations of the VHL tumour suppressor gene in renal carcinoma | Q42806703 | ||
Novel mutations of the MET proto-oncogene in papillary renal carcinomas. | Q42815807 | ||
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas | Q45345804 | ||
Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435. | Q53478798 | ||
Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families. | Q55312690 | ||
Direct Interaction of the β-Domain of VHL Tumor Suppressor Protein with the Regulatory Domain of Atypical PKC Isotypes | Q58323654 | ||
High incidence of papillary renal cell tumours in patients on chronic haemodialysis | Q70613373 | ||
Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) | Q73722184 | ||
TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) | Q73722193 | ||
Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization | Q77976437 | ||
P433 | issue | 4 | |
P921 | main subject | von Hippel-Lindau disease | Q741315 |
P304 | page(s) | 359-364 | |
P577 | publication date | 2002-12-01 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney | |
P478 | volume | 35 |
Q83021140 | Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study |
Q53586772 | Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population. |
Q34092758 | Genomic profiling of renal cell carcinoma in patients with end-stage renal disease |
Q37069569 | Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors |
Q35027407 | Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule |
Q47879190 | Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma |
Q37778312 | Perspectives in drug development for metastatic renal cell cancer |
Q37507517 | Uncommon and recently described renal carcinomas |
Search more.